Keyphrases
Atrial Fibrillation
100%
Anticoagulants
100%
GLORIA
100%
SAMe-TT2R2 Score
100%
Vitamin K Antagonists
50%
Anticoagulation
25%
International Registry
25%
Anticoagulated Patients
25%
Randomized Controlled Trial
12%
Clinical Practice
12%
Clinical Characteristics
12%
Safety Profile
12%
Efficacy Profile
12%
Antithrombotic Therapy
12%
Clinical Trial Registry
12%
Relative Efficacy
12%
Stroke Risk Factors
12%
Relative Safety
12%
Anticoagulation Control
12%
Target-specific Oral Anticoagulants
12%
Clinical Outcomes
12%
New-onset Atrial Fibrillation
12%
Neuroscience
Anticoagulant
100%
Antithrombotic
100%
Atrial Fibrillation
100%
Vitamin K Antagonist
50%
Randomized Controlled Trial
12%
Cerebrovascular Accident
12%
Medicine and Dentistry
Antithrombotic
100%
Atrial Fibrillation
100%
Vitamin K Antagonist
50%
Anticoagulation
37%
Apoplexy
12%
Clinical Trial
12%
Randomized Controlled Trial
12%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Atrial Fibrillation
100%
Antivitamin K
50%
Randomized Controlled Trial
12%
Clinical Trial
12%
Cerebrovascular Accident
12%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Vitamin K
50%
Anticoagulation
37%
Clinical Trial
12%
Randomized Controlled Trial
12%